Wugen, Inc.: Wugen Presents Preclinical Data on WU-NK-101 in Solid Tumor Models at the European Society for Medical Oncology (ESMO) Congress 2022

-- WU-NK-101 exhibited enhanced metabolic fitness and adaptability, enabling superior resilience within the immunosuppressive solid tumor microenvironment and preserved cytotoxic function -- --

Related Keywords

Paris ,France General ,France ,Kostenloser Wertpapierhandel ,Dan Kemp ,Sergio Rutella ,Elsie Yau ,Stern Investor Relations Inc ,Wugen Inc ,European Society For Medical Oncology ,European Society ,Medical Oncology ,Chief Executive Officer ,Nottingham Trent University ,Therapy Optimized ,Tumor Microenvironment ,Paris Expo Porte De Versailles ,Poster Area ,Stern Investor Relations ,Wugen ,Presents ,Reclinical ,Data ,Olid ,Humor ,Models ,European ,Society ,Medical ,Ncology ,Osmo ,Congress ,022 ,